Citations

Showing 10 of 108083 citations.

PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination
Memarnejadian, Arash , Meilleur, Courtney, Shaler, Christopher R. , Khazaie, Khashayarsha , Bennink, Jack R., Schell, Todd D. , Haeryfar, S. M. Mansour

Mayo Clinic

The Journal of Immunology | September 23, 2017 | Volume: 199 | Issue: 9 | Pages: 3348-3359

10.4049/jimmunol.1700643 | PMID 28939757 Get It

Abstract The interactions between programmed death-1 (PD-1) and its ligands hamper tumor-specific CD8+ T cell (TCD8) responses, and PD-1-based “checkpoint inhibitors” have shown promise in certain cancers, thus revitalizing interest in immunotherapy. PD-1–targeted therapies reverse TCD8 exhaustion/anergy. However, whether they alter the epitope breadth of TCD8 responses remains unclear. This is an important question because subdominant TCD8 are more likely than immunodominant clones to escape tolerance mechanisms and may contribute to protective anticancer immunity. We have addressed this question in an in vivo model of TCD8 responses to well-defined epitopes of a clinically relevant oncoprotein, large T Ag. We found that unlike other coinhibitory molecules (CTLA-4, LAG-3, TIM-3), PD-1 was highly expressed by subdominant TCD8, which correlated with their propensity to favorably respond to PD-1/PD-1 ligand-1 (PD-L1)-blocking Abs. PD-1 blockade increased the size of subdominant TCD8 clones at the peak of their primary response, and it also sustained their presence, thus giving rise to an enlarged memory pool. The expanded population was fully functional as judged by IFN-γ production and MHC class I–restricted cytotoxicity. The selective increase in subdominant TCD8 clonal size was due to their enhanced survival, not proliferation. Further mechanistic studies utilizing peptide-pulsed dendritic cells, recombinant vaccinia viruses encoding full-length T Ag or epitope mingenes, and tumor cells expressing T Ag variants revealed that anti–PD-1 invigorates subdominant TCD8 responses by relieving their lysis-dependent suppression by immunodominant TCD8. To our knowledge, our work constitutes the first report that interfering with PD-1 signaling potentiates epitope spreading in tumor-specific responses, a finding with clear implications for cancer immunotherapy and vaccination.
In Reply
Dowdy, Sean C. , Lovely, Jenna K. , Bakkum‐Gamez, Jamie N.

Mayo Clinic

Obstetrics & Gynecology | September 22, 2017 | Volume: 130 | Issue: 4 | Pages: 914-915

10.1097/aog.0000000000002304 | PMID 28937562 Get It

Behind the Curtain: What Makes the Land of OB GYN Appealing to Our Students
Green, Isabel, Riddle, Julia, Green, Isabel C.

Mayo Clinic

Obstetrics & Gynecology | September 22, 2017 | Volume: 130 | Issue: 1 | Pages: 46S-46S

10.1097/01.aog.0000525738.56306.4e Get It

BACKGROUND: In 2005, in response to a decline in residency applications in OBGYN, the American College of Obstetrics and Gynecology Presidential Task Force outlined strategies for attracting medical students to OBGYN. Our program implemented interventions across all years of medical school education, increased efforts to “teach the teachers,” and improve faculty and resident relations with students. Application rates increased, but little is still known about which interventions work. METHODS: This qualitative study received IRB approval. Students applying or recently matched into OB GYN residency programs from the Class of 2014–2016 were included. Eleven participants completed a phone interview exploring why they chose OB GYN, focusing on positive and negatives experiences. The survey instrument was designed to include open ended questions and a Likert-type survey. Grounded theory methodology was used for analysis. Participants received a $50 Starbucks card. RESULTS: Preliminary analysis identified the following themes: 1) potential for a “meaningful” job and a future role in women's health, advocacy for women or empowerment of women; 2) first impressions in the clinical clerkship and “welcoming” teams; 3) content and diversity of our field; 4) impact of supportive mentors in career decisions. DISCUSSION: Participants identify important events that even precede medical school, but commonly highlight finding meaning in their work, and identifying with others that share in their interest and goals as guiding them toward OB GYN.
Establishing Extrapolation Evidence for the MyTIPreport Feedback Application Using a Contemporary Validation Approach
DeStephano, Christopher C. , Dinh, Tri, Seibel, Brent E., McCullough, Deanna C. , Best, Kelly

Mayo Clinic

Obstetrics & Gynecology | September 22, 2017 | Volume: 130 | Issue: 1 | Pages: 42S-42S

10.1097/01.aog.0000525724.64822.25 Get It

BACKGROUND: OB/GYN residencies use myTIPreport to improve resident feedback. Validation is viewed as a process with construct validity established from different levels of evidence. In Kane's validity framework, extrapolation focuses on links between assessment outcomes and other measures of performance. METHODS: Single-institution, prospective cohort study of OB/GYN residents (n=24). Using the ACGME case log system and myTIPreport application, associations of PGY level, number of previous hysteroscopies (HSC), total vaginal hysterectomies (TVH), and total abdominal hysterectomies (TAH) with myTIPreport ratings of each procedure when performed in the operating room were assessed using Spearman's test correlation. A pilot study of inexpensive, low technology simulation models was initiated to assess extrapolation evidence for myTIPreport in the simulation setting (n=8). RESULTS: Associations (P<.01) existed between PGY level and myTIPreport scores in the OR (r=0.612 for HSC, r=0.763 for TAH, r=0.864 for TVH). Associations (P<.01) existed between number of procedures performed and myTIPreport scores in the OR (r=0.587 for HSC, r=0.681 for TAH, r=0.869 for TVH). An association (r=0.852, P=.031) existed between number of TVHs performed in the OR and myTIPreport scores during simulation, but not for TAH (P=.199) nor HSC (P=.154) due to the small sample size. DISCUSSION: The association between myTIPreport TVH performance with PGY level and number of TVHs was the strongest, supporting extrapolation evidence. The associations were weaker for TAH and HSC in both the OR and simulation settings secondary to higher ratings for lower PGY levels and fewer cases.
ARHGEF28 p.Lys280Metfs40Ter in an amyotrophic lateral sclerosis family with a C9orf72 expansion
Petrucelli, Leonard , Strong, Michael J. , Farhan, Sali M K, Gendron, Tania F. , Hegele, Robert A, Strong, Michael J , Farhan, Sali M K , Hegele, Robert Alexander

Mayo Clinic

Neurology Genetics | September 22, 2017 | Volume: 3 | Issue: 5 | Pages: No page available

10.1212/nxg.0000000000000190 | PMID 28971145 Get It

CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
Avril, Tony , Etcheverry, Amandine, Pineau, Raphaël , Obacz, Joanna , Jégou, Gwénaële, Jouan, Florence, Reste, Pierre‐Jean Le , Hatami, Masumeh, Colen, Rivka R. , Carlson, Brett L. , Decker, Paul A. , Vauléon, Élodie , Chiforeanu, Dan Cristian, Mosser, Jean, Chevet, Éric , Quillien, Véronique , Decker, Paul A. , Sarkaria, Jann N. , Clavreul, Anne , Chevet, Eric

Mayo Clinic

Clinical Cancer Research | September 22, 2017 | Volume: 23 | Issue: 23 | Pages: 7360-7374

10.1158/1078-0432.ccr-17-1549 | PMID 28939749 Get It

Abstract Purpose: CD90 (Thy-1) is a glycophosphatidylinositol-anchored glycoprotein considered as a surrogate marker for a variety of stem cells, including glioblastoma (GBM) stem cells (GSC). However, the molecular and cellular functions of CD90 remain unclear. Experimental Design: The function of CD90 in GBM was addressed using cellular models from immortalized and primary GBM lines, in vivo orthotopic mouse models, and GBM specimens' transcriptome associated with MRI features from GBM patients. CD90 expression was silenced in U251 and GBM primary cells and complemented in CD90-negative U87 cells. Results: We showed that CD90 is not only expressed on GSCs but also on more differentiated GBM cancer cells. In GBM patients, CD90 expression was associated with an adhesion/migration gene signature and with invasive tumor features. Modulation of CD90 expression in GBM cells dramatically affected their adhesion and migration properties. Moreover, orthotopic xenografts revealed that CD90 expression induced invasive phenotypes in vivo. Indeed, CD90 expression led to enhanced SRC and FAK signaling in our GBM cellular models and GBM patients' specimens. Pharmacologic inhibition of these signaling nodes blunted adhesion and migration in CD90-positive cells. Remarkably, dasatinib blunted CD90-dependent GBM cell invasion in vivo and killed CD90high primary GSC lines. Conclusions: Our data demonstrate that CD90 is an actor of GBM invasiveness through SRC-dependent mechanisms and could be used as a predictive factor for dasatinib response in CD90high GBM patients. Clin Cancer Res; 23(23); 7360–74. ©2017 AACR.
Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients
Valdez, Clarissa , Wong, Yvette C. , Schwake, Michael , Bu, Guojun , Krainc, Dimitri , Bu, Guojun , Wszołek, Zbigniew K.

Mayo Clinic

Human Molecular Genetics | September 22, 2017 | Volume: 26 | Issue: 24 | Pages: 4861-4872

10.1093/hmg/ddx364 | PMID 29036611 Get It

Effect of parathyroidectomy on osteopontin and undercarboxylated osteocalcin in patients with primary hyperparathyroidism
Maser, Raelene E., Lenhard, M. James , Pohlig, Ryan T. , Balagopal, Prabhakaran , Abdel‐Misih, Raafat

Mayo Clinic

Endocrine Research | September 22, 2017 | Volume: 43 | Issue: 1 | Pages: 21-28

10.1080/07435800.2017.1369432 | PMID 28937873 Get It

Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study
Tremaine, William J., Raffals, Laura E. , Kane, Sunanda V. , Loftus, Edward V. , Aniwan, Satimai , Loftus, Edward V

Mayo Clinic

Journal of Crohn's and Colitis | September 22, 2017 | Volume: 12 | Issue: 2 | Pages: 137-144

10.1093/ecco-jcc/jjx135 | PMID 29029150 Get It

Video‐assisted microwave ablation for the treatment of a metastatic lung lesion in a dog with appendicular osteosarcoma and hypertrophic osteopathy
Mazzaccari, Kaitlyn M., Boston, Sarah E., Toskich, Beau , Bowles, Kristina D., Case, J. Brad , Toskich, Beau B.

Mayo Clinic

Veterinary Surgery | September 22, 2017 | Volume: 46 | Issue: 8 | Pages: 1161-1165

10.1111/vsu.12723 | PMID 28940654 Get It

AbstractObjectiveTo describe video‐assisted microwave ablation (VAMA) for the treatment of a metastatic lung lesion secondary to right forelimb osteosarcoma in a dog.Study designCase report.AnimalsA 10‐year‐old female spayed mixed breed dog with a metastatic lung lesion secondary to appendicular osteosarcoma.MethodsAn osteosarcoma of the right distal scapula and proximal humerus that was suspected to be a radiation‐induced osteosarcoma was treated with limb amputation and carboplatin chemotherapy. The patient developed pulmonary metastatic lesions and hypertrophic osteopathy (HO). VAMA of a metastatic lesion in the right caudal lung lobe was performed 227 days after amputation. The procedure was performed without complication.ResultsFollow‐up information with the referring veterinarian 40 days after VAMA indicated that the patient was stable and that the clinical signs of HO had resolved. Thoracic radiographs taken by the referring veterinarian (RDVM) at monthly intervals showed that the previously treated metastatic lesion was stable. At 134 days from VAMA, the patient presented to the RDVM for lethargy and dyspnea and was transferred to an emergency clinic. The patient arrested and died 136 days from the VAMA procedure while hospitalized. A postmortem was not performed.ConclusionVAMA for pulmonary metastatic lesions is technically feasible and allows for the treatment of symptoms associated with HO and minimally invasive management of pulmonary metastases in the case reported.